Nectar Lifesciences Limited (LUX: NECLF)

Nectar Lifesciences Ratios and Metrics

Market cap in millions EUR. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 26, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	100	75	40	64	49	27
Market Cap Growth	56.32%	87.63%	-37.34%	31.70%	82.90%	-46.61%
Enterprise Value	168	149	127	170	129	110
Last Close Price	0.37	0.34	0.18	0.29	0.22	0.12
PE Ratio	86.90	135.36	-	21.53	-	6.91
PS Ratio	0.54	0.40	0.23	0.32	0.27	0.09
PB Ratio	0.84	0.63	0.34	0.50	0.39	0.19
P/TBV Ratio	0.88	0.66	0.35	0.52	0.41	0.20
P/FCF Ratio	6.65	3.46	3.45	7.70	-	0.95
P/OCF Ratio	5.73	3.01	2.68	5.68	19.51	0.77
EV/Sales Ratio	0.89	0.79	0.74	0.86	0.72	0.38
EV/EBITDA Ratio	8.58	8.71	21.00	9.02	10.04	4.12
EV/EBIT Ratio	13.22	14.40	-	14.07	22.13	5.69
EV/FCF Ratio	11.53	6.85	10.94	20.42	-	3.94
Debt / Equity Ratio	0.58	0.59	0.71	0.79	0.85	0.69
Debt / EBITDA Ratio	3.61	4.14	13.97	5.42	8.19	3.54
Debt / FCF Ratio	4.61	3.25	7.28	12.28	-	3.38
Asset Turnover	0.78	0.77	0.67	0.70	0.61	0.89
Inventory Turnover	1.67	1.59	1.60	1.78	1.39	1.93
Quick Ratio	0.41	0.45	0.41	0.53	0.38	0.38
Current Ratio	1.31	1.32	1.38	1.35	1.04	1.29
Return on Equity (ROE)	1.00%	0.47%	-2.25%	2.33%	-6.67%	2.84%
Return on Assets (ROA)	3.27%	2.65%	-0.14%	2.66%	1.24%	3.73%
Return on Capital (ROIC)	4.09%	3.29%	-0.17%	3.25%	1.61%	5.08%
Earnings Yield	1.18%	0.74%	-6.76%	4.64%	-17.56%	14.46%
FCF Yield	15.03%	28.88%	28.96%	12.99%	-2.36%	104.74%
Dividend Yield	0.00%	-	-	-	-	0.51%
Payout Ratio	0.00%	-	-	-	-	3.53%
Total Shareholder Return	-2.93%	-	-	-	-	0.51%

Source: S&P Capital IQ. Standard template. Financial Sources.